Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19
about
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesComplement in age-related macular degeneration: a focus on functionViolet and blue light blocking intraocular lenses: photoprotection versus photoreceptionThe LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samplesGenetics and age-related macular degeneration: a practical review for the clinicianAflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degenerationNLRP3 Inflammasome and Pathobiology in AMDNutrient Supplementation for Age-related Macular Degeneration, Cataract, and Dry EyeCritical review: vegetables and fruit in the prevention of chronic diseasesAdvances in the genomics of common eye diseasesAlternative complement pathway deficiency ameliorates chronic smoke-induced functional and morphological ocular injuryGeographic Atrophy and Choroidal Neovascularization in the Same Eye: A ReviewRecent developments in the management of dry age-related macular degenerationOverexpression of HTRA1 leads to ultrastructural changes in the elastic layer of Bruch's membrane via cleavage of extracellular matrix componentsLOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysisTreatment of age-related macular degeneration.Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.A review of drug options in age-related macular degeneration therapy and potential new agents.Density of common complex ocular traits in the aging eye: analysis of secondary traits in genome-wide association studiesChronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice.Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.Changes in retinal pigment epithelium related to cigarette smoke: possible relevance to smoking as a risk factor for age-related macular degeneration.The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary studyDevelopment of a risk score for geographic atrophy in complications of the age-related macular degeneration prevention trial.Risk factors for age-related maculopathyPrevalence of and risk factors for age-related macular degeneration in Nepal: the Bhaktapur Retina StudyA Review of Current and Future Management of Geographic Atrophy.Distinct signature of altered homeostasis in aging rod photoreceptors: implications for retinal diseases.The inhibition of NOTCH2 reduces UVB-induced damage in retinal pigment epithelium cells.Ranibizumab for the treatment of degenerative ocular conditions.Patients' knowledge and perspectives on wet age-related macular degeneration and its treatment.Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms.In-depth analyses unveil the association and possible functional involvement of novel RAD51B polymorphisms in age-related macular degeneration.Analysis of single nucleotide polymorphisms in the NOS2A gene and interaction with smoking in age-related macular degenerationToll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samplesCigarette smoke-related hydroquinone induces filamentous actin reorganization and heat shock protein 27 phosphorylation through p38 and extracellular signal-regulated kinase 1/2 in retinal pigment epithelium: implications for age-related macular degFive-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study.Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis.Angiotensin II-related hypertension and eye diseases.
P2860
Q24242944-8736D6C1-214A-47FE-B893-AF99CE471B02Q24635874-690B1750-CC6E-4FFF-B03A-35959CD4C038Q24676430-4720C406-6906-4EED-B575-F92F76887359Q24678569-F11988C4-3429-48AE-83C2-F3A093E45496Q26738526-7C77A2C3-4C10-4FA0-8C01-C83FBF900F3DQ26771522-817074C8-86FF-472A-A651-BBAF7D738DDBQ26799766-5AC5E6CE-1495-4CF6-8D89-5DD89574D272Q26821899-659FB596-BD86-471F-8F4D-E03C30CE4816Q26998728-0D1D25C2-5F03-4D36-9EAD-19EFA09B18E1Q27008236-68233E13-8065-48E1-B3B2-190D2A33C1D1Q27311630-C60B94EB-E929-4F14-9756-02C17DD7881DQ28074640-04446C79-E5D1-4D6C-AF30-8B8C988D183BQ28088816-81A7127D-E2BC-4034-ADE1-01FAA2DE19B1Q28741873-13D44DD4-389C-4AA8-B855-7CBFCDE8B164Q32125469-886BACAE-7BB7-4958-9847-51F5B989D13BQ33226171-79FAB381-9666-4FD3-A40A-21EF0440BFB0Q33263472-92B1FDB5-AC07-444C-A8E3-3C7B82579830Q33263803-BE9C621B-0F9E-44C3-8AE8-09070B97156FQ33346235-0F96E62F-7EE5-44F8-A621-DB224536D973Q33366509-F9E2528F-7ED1-4D53-A7AB-A1F8F96F9181Q33396798-A9A7E882-525F-41F3-AA0A-84878498BB29Q33434526-04CAC96D-85AC-4295-B31B-768E0A160E70Q33613367-B4A89B2A-2B22-41B8-897E-124AAD9114A6Q33616519-7BF87321-12DD-478F-B984-D8B8BEB01388Q33676775-D629D454-B6FE-4DBE-9A9F-EAF4D1029A47Q33720834-E2C59248-841A-42A8-8D38-1D0E93A0902BQ33739809-21F2AB72-8DE2-4E7C-A9A5-0D758E950F9AQ33740158-A3FA016D-F16F-4B2F-9456-9AC4AB2EA369Q33747656-0F4E1813-EB6A-400A-9124-8282C7006AB1Q33828306-68B0D00C-FF5E-4359-B5A7-C23C955DABA8Q33831237-719E7AA2-FD95-4EDD-95A7-A127F7565B81Q33837372-195B175A-F6BC-4886-A7DB-1D984E7936ECQ33844950-6FBA0C5C-3616-46E7-88E9-C96534660160Q33848714-47904314-B5AE-47C9-BD44-B7EBBCFC6F05Q33903086-4495DBCE-D131-4D14-BA1E-15D666500446Q33950814-99E42852-FC60-4114-9B90-E1C89FCCEFBAQ34086893-B0C39BC1-587A-4FCD-BE45-06F555432035Q34090408-3DF6855B-63BD-40CF-BA23-969F02A2CFECQ34114772-4ECF40FF-6DD0-4BBF-A35B-C688D4A83FE9Q34251889-F5B8970B-898B-40CE-923E-9C2B29FBF79F
P2860
Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Risk factors for the incidence ...... dy (AREDS) AREDS report no. 19
@ast
Risk factors for the incidence ...... dy (AREDS) AREDS report no. 19
@en
Risk factors for the incidence ...... dy (AREDS) AREDS report no. 19
@nl
type
label
Risk factors for the incidence ...... dy (AREDS) AREDS report no. 19
@ast
Risk factors for the incidence ...... dy (AREDS) AREDS report no. 19
@en
Risk factors for the incidence ...... dy (AREDS) AREDS report no. 19
@nl
prefLabel
Risk factors for the incidence ...... dy (AREDS) AREDS report no. 19
@ast
Risk factors for the incidence ...... dy (AREDS) AREDS report no. 19
@en
Risk factors for the incidence ...... dy (AREDS) AREDS report no. 19
@nl
P2093
P2860
P3181
P1433
P1476
Risk factors for the incidence ...... dy (AREDS) AREDS report no. 19
@en
P2093
Frederick L Ferris
Johanna M Seddon
Ronald Klein
Roy C Milton
Traci E Clemons
P2860
P3181
P356
10.1016/J.OPHTHA.2004.10.047
P407
P577
2005-04-01T00:00:00Z